Beyond Blanket Recommendations: A Risk-Based Approach to Vaccination
Tailoring Immunization Strategies to Protect Those Who Need It Most
mRNA & Future Vaccines
‘It’s huge’: Vaccine for melanoma found to reduce recurrence, death by half - National | Globalnews.ca
but mRNA vaccines...blah blah
Just wow. This *is huge - especially since its known that mRNA vaccines are *very specific with which illnesses they respond well to. I'm glad this is one of them!
Penn Medicine Develops mRNA Vaccine Against Lyme Disease
An experimental mRNA vaccine provides protection in preclinical animal models against infection from Borrelia burgdorferi, the bacteria that causes Lyme disease. Results suggest that the vaccine prevents the development of Lyme disease.
Brain cancer in children is notoriously hard to treat – a new mRNA cancer vaccine triggers an attack from within
Cancer vaccines have gained much interest among scientists but face a number of hurdles. A new mRNA vaccine for glioma offers a step forward in training the immune system to fight cancer.
Startup Dalan Animal Health Makes A Vaccine For Honeybees. Shrimp Are Next.
Dalan Animal Health is working to sell its bee vaccines to commercial beekeepers and governments – and potentially expand to other invertebrates.
https://www-vox-com.cdn.ampproject.org/c/s/www.vox.com/platform/amp/future-perfect/22307700/malaria-rna-vaccines-covid-19?utm_source=pocket_mylist
How new vaccine technologies could reduce the massive death toll from malaria
There’s still a long way to go, but RNA vaccines might help in the fight against malaria.
COVID-19 vaccine results might inform malaria vaccine strategies
Interim Com-COV2 trial data evaluated two-dose COVID-19 vaccination regimens with
first dose of BNT162b2 (Pfizer-BioNTech) or ChAdOx1 nCoV-19 (Oxford-AstraZeneca) alongside
second dose as either homologous vaccination, heterologous NVX-CoV2373 (Novavax) vaccination,
or heterologous mRNA-1273 (Moderna) vaccination.1 These data showed that ChAdOx1 nCoV-19
vaccination followed by NVX-CoV2373 vaccination drove optimal T-cell immunogenicity
and excellent antibody induction. These heterologous vaccine approach findings are
now likely to be extrapolated in developing scheduling strategies for other vaccines.
China is changing its tune on the mRNA vaccine
Beijing approves the first vaccine of its kind as it looks to jumpstart its flailing economy
COVID: China is developing its own mRNA vaccine – and it’s showing early promise
Having access to an mRNA vaccine will be critical to China’s ongoing COVID response.
China approves first home-grown mRNA Covid vaccine
China's labs have spent years trying to create an mRNA vaccine - its own shots were less effective.
China’s mRNA Vaccine Industry: A Latecomer's Prospects
Bridge Consulting examines the opportunities and challenges ahead for China’s mRNA vaccine industry in the post-COVID era. Having eschewed foreign-made mRNA products from Pfizer/BioNTech and Moderna during the peak of the pandemic in the hope of securing domestic alternatives, China and its sizeable biopharma industry now face a challenging path ahead to catch up to…
‘All-In-One’ Vaccine Could Protect Against Future Covid-19 Variants, Researchers Say
Researchers from the California Institute of Technology say the “mosaic-8” vaccine could protect people from other coronaviruses, including SARS and MERS.
New vaccine technology could protect from future viruses and variants
Studies of a ‘future-proof’ vaccine candidate have shown that just one antigen can be modified to provide a broadly protective immune response in animals. The